Raytheon Technologies’ (NYSE:RTX) Board of Directors authorized today the repurchase of up to $6 billion of the company’s outstanding common stock. The new authorization replaces the company’s previous program, approved Dec. 7, 2021. Share repurchases may take place from time to time, subject to market conditions and at the company’s discretion, in the open market, through privately negotiated transactions or other means.
Entera Bio Reports Rapid Pharmacodynamic Response And Consistent Pharmacokinetic Data For Its First-In-Class Oral PTH(1-34) Mini Tablets At The ASBMR 2023 Annual Meeting
Entera Bio Ltd. (NASDAQ:ENTX), ("Entera" or the "Company") a leader in the development of orally delivered peptides and therapeutic proteins, presented 2 posters at the Annual Society of Bone and Mineral Research (ASBMR)
